Tango Therapeutics, Inc. ($TNGX)
Filing Information
| Accession Number | 0001193125-26-140874 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 3, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
81,000
Total Value
$712,878.30
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D | Common Stock | โ | Apr 1, 2026 | Exercise/Conversion | 27,000 | $5.20 | $140,400.00 | 139,622 | Direct | โ | View Details | |
President, R&D | Common Stock | โ | Apr 1, 2026 | Sale | 27,000 | $21.20 | $572,478.30 | 112,622 | Direct | โ | View Details | |
President, R&D | Stock Option (Right to Buy) | Derivative | Apr 1, 2026 | Exercise/Conversion | 27,000 | $0.00 | $0.00 | 433,500 | Direct | โ | View Details |